Your browser doesn't support javascript.
loading
Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.
Hooper, Perry B; Farberg, Aaron S; Fitzgerald, Alison L; Siegel, Jennifer J; Rackley, Briana B; Prasai, Anesh; Kurley, Sarah J; Goldberg, Matthew S; Litchman, Graham H.
Afiliação
  • Hooper PB; Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Farberg AS; Baylor Scott & White Health System, Dallas, TX, USA.
  • Fitzgerald AL; Castle Biosciences, Inc, Friendswood, TX, USA.
  • Siegel JJ; Castle Biosciences, Inc, Friendswood, TX, USA.
  • Rackley BB; Castle Biosciences, Inc, Friendswood, TX, USA.
  • Prasai A; Castle Biosciences, Inc, Friendswood, TX, USA.
  • Kurley SJ; Castle Biosciences, Inc, Friendswood, TX, USA.
  • Goldberg MS; Castle Biosciences, Inc, Friendswood, TX, USA.
  • Litchman GH; St. John's Episcopal Hospital, Far Rockaway, NY, USA.
Cancer Invest ; 40(10): 911-922, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36073945
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Células Escamosas Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Células Escamosas Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article